Companion Medical said today that it won FDA clearance for the Android version of its InPen app.
The company’s InPen system consists of a smart insulin injection pen that connects with an integrated diabetes management app. Companion Medical expects to release the app for Android users by the fourth quarter of this year.
“We are excited to make the InPen system available for Android devices so that we can bring the latest in connected diabetes technology to Android users,” Companion’s CEO Sean Saint said in prepared remarks. “Our mission is to empower people living with diabetes and their healthcare providers with easy-to-use connected solutions that improve outcomes at a lower cost. With diabetes, it is about taking the right amount of insulin at the right time. InPen’s dose calculator, insulin-on-board tracking, and dose reminders do all the tracking, monitoring, and complex calculations for users, while also providing healthcare professionals with the data they need.”
Last month, the company launched Insights by InPen, a diabetes management system that aggregates and analyzes data from its connected insulin injection pen.
The company’s Insights by InPen system provides users with their average glucose, average total daily insulin dose, dose calculator usage, missed doses and more. The system is available in the U.S. by prescription only.
Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW |
Drug Delivery Business News
@DrugDeliveryNow
LinkedIn
Leave a Reply